Abstract | BACKGROUND: OBJECTIVE: To better understand the clinical spectrum, risk factors and outcomes in MOGAD. METHODS: Retrospective cohort study including all subjects harboring anti-MOG antibodies identified in major academic hospitals across the province of Quebec. RESULTS: We identified 45 MOGAD cases. The minimal estimated point-prevalence was 0.52/100 000 in Quebec. Median age at presentation was 32 years (range 1-71) with equal sex ratio. Most frequent ethnic groups were Caucasians and Asians. The most frequent clinical manifestations at onset were optic neuritis (ON), affecting 56% of adults, and acute disseminated encephalomyelitis (ADEM), affecting 33% of children. First MRI was abnormal in 84% of cases. Most CSF samples showed pleocytosis without oligoclonal bands. Two brain biopsies revealed lipid-laden macrophages and reactive astrocytes. Despite steroids, only 38% had fully recovered at 4 weeks after onset. Half of pediatric and two thirds of adult-onset MOGAD subjects experienced relapses. At last follow-up, 69% showed residual deficits, which were moderate to severe in 17% of adults. CONCLUSION: MOGAD has heterogeneous disease course, and it is not a benign disease for a substantial proportion of adults. Best disease-modifying therapies remain to be determined.
|
Authors | Hayet Boudjani, Giulia Fadda, Gabrielle Dufort, Jack Antel, Paul Giacomini, Myriam Levesque-Roy, Maryam Oskoui, Pierre Duquette, Alexandre Prat, Marc Girard, Rose-Marie Rebillard, Inge Meijer, Elana Pinchefsky, Cam-Tu Emilie Nguyen, Elsa Rossignol, Jacinthe Rouleau, Oliver Blanchard, Nicole Khairallah, Philippe Beauchemin, Anne-Marie Trudelle, Emmanuelle Lapointe, Alexander Saveriano, Catherine Larochelle |
Journal | Multiple sclerosis and related disorders
(Mult Scler Relat Disord)
Vol. 76
Pg. 104787
(Aug 2023)
ISSN: 2211-0356 [Electronic] Netherlands |
PMID | 37320939
(Publication Type: Journal Article)
|
Copyright | Crown Copyright © 2023. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Myelin-Oligodendrocyte Glycoprotein
- Autoantibodies
|
Topics |
- Humans
- Myelin-Oligodendrocyte Glycoprotein
- Retrospective Studies
- Encephalomyelitis, Acute Disseminated
(diagnostic imaging)
- Optic Neuritis
- Disease Progression
- Autoantibodies
|